This case follows Minerva Advisor's existing verification process, not a new demonstration format, and no case-specific product mode has been added. The material comes from AlixPartners' official public case. We isolate outcomes disclosed later, then rebuild only what was knowable at the decision point into an educational package. This is an independent teaching simulation, not real correspondence, and not real client results. AlixPartners did not use, review, endorse, sponsor, certify, or commission Minerva Advisor. What follows is evidence about how the product evaluates a decision, not evidence about any customer's actual outcome.

The situation: an aircraft manufacturer had cycled through three chief executives in one year. Its stock price fell 45 percent in two months, and earnings before interest and taxes turned negative. A major new product ran behind schedule and kept consuming cash, while public reporting turned pessimistic and customer confidence slipped. The board faced a choice: demand immediate across-the-board cuts and cash actions, or first launch a time-boxed, stoppable diagnostic of product delivery and cash drivers. Minerva Advisor was asked to weigh both paths and state the minimum evidence, accountability, and escalation conditions required before committing.

Before any recommendation, Minerva produced a five-item work receipt any executive can audit. One, it worked from a single verified source. Two, it identified four distinct decision-making roles. Three, it separated six confirmed facts, two inferences, and three unresolved items rather than blending them. Four, it compared exactly two competing paths, immediate cuts versus a time-boxed diagnostic. Five, it preserved three alternative interpretations of the crisis along with one explicit reversal condition. That receipt is a traceable record of the reasoning performed, not a summary written afterward.

What was known: leadership turmoil from three CEO changes, a sharp stock price decline, negative earnings, a delayed flagship product still consuming liquidity, and eroding customer confidence. What was not known: the actual cash runway, the nearest upcoming obligations, the true critical path behind the delay, and the net impact different cut options would have on delivery and customer confidence. Minerva did not treat urgency as a substitute for that missing evidence.

Minerva preserved its own strongest challenge rather than hiding it. The leadership churn and confidence collapse might reflect a governance failure no diagnostic could fix. Cuts could instead be targeted only at non-critical overhead, avoiding the delivery tradeoff entirely. And market confidence might already be too damaged for a time-boxed diagnostic to preserve, meaning visible immediate action could be the only lever left. The reversal condition: if the liquidity runway, once measured, proves shorter than the diagnostic's time-box, the board must immediately mandate across-the-board cuts rather than wait for the diagnostic to finish.

AlixPartners' later-disclosed answer was deliberately withheld from the input. The fragmented-supplier diagnosis, the bottom-up improvement idea pipeline, the procurement, lean, and capital expenditure modules, the governance cadence built with management and the board, and the eventual cash, earnings, and stock price gains were all excluded. Minerva Advisor did not know the official turnaround approach in advance and was not scored against it. It was tested only on whether it could sequence triage and diagnosis correctly under crisis conditions, using only what was knowable at the time.

Three advisors then cross-checked the same judgment. Marcus focused the real question on whether the cash runway actually permitted a short assessment window. Sofia modeled second-order consequences across product, finance, commercial, and board relationships. Evelyn directly challenged whether a diagnostic would simply become a slow-motion delay. All three converged on the same direction, a short, stoppable assessment of product and cash, but insisted the safe time limit be reverse-calculated first, not assumed.

The executive brought back one condition: reverse-calculate the diagnostic's time limit using the most conservative cash runway assumption, investigate the product delay's critical path in parallel, and stop the diagnosis immediately, escalating to full triage, the moment the runway proves shorter than the time-box. Minerva recorded this as a response receipt: the original judgment was maintained, and the stop conditions were formally reinforced rather than treated as an afterthought.

Weighing the options directly: across-the-board cuts reduce cash outflow quickly, but with the delay's critical path unclear, they risk damaging certification, delivery, and customer confidence in ways hard to reverse. The time-boxed diagnostic preserves room for precise, targeted triage, at the cost of a very short amount of time before a decision is forced. The executive chose the diagnostic path, paired with an immediate reversal trigger at the first sign of a cash breakpoint.

The committed action: product and finance leads will submit the cash runway, the nearest upcoming obligations, and the product delay's critical path within a short, fixed deadline, with stop and board-escalation signals documented in advance. Minerva Advisor tracks that this action was committed. It does not claim, and this simulation does not claim, that cash position, earnings, or stock price actually improved as a result.

This case passed all ten of ten decision-quality checks. The actual run used four model calls, delivered its first decision in 17.504 seconds, and reached a complete result in 25.494 seconds, passing both the 30-second first-decision threshold and the 45-second complete-result threshold. Decision quality, executive experience, and performance all passed. This remains a single independent teaching simulation, not a production-level service guarantee, and not a record of real client outcomes.